Taja Zore

Taja Zore
no.: 52377 source: ARIS

researcher – not employed in research organisation
  taja.zoreat signffa.uni-lj.si
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
81.31
A''
0
A'
62.07
A1/2
70.78
CI10
13
CImax
7
h10
2
A1
0.31
A3
0
Data for the last 5 years (citations for the last 10 years) on November 10, 2025; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 3  13  11  3.67 
Scopus 4  15  13  3.25 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
2nd cycle master's degree      SI University of Ljubljana, Faculty of Pharmacy 2018 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J3-4527  Muscle cell secretom and bone cells interplay in osteosarcopenia (MiKOSA)   10/1/2022 - 9/30/2025  PhD Janja Marc   3,907 
2. J3-3062  Autologous immunohybridomas and advanced treatment of stage II and III triple-negative breast cancer   10/1/2021 - 9/30/2025  PhD Matjaž Jeras   2,776 
3. L3-3176  The Role and Potential Application of Immunomodulatory Mesenchymal Stem Cells in COVID- 19 Disease   10/1/2021 - 9/30/2024  PhD Janja Zupan   3,692 
4. J3-1749  Mesenchymal stem cells-the keepers of tissue endogenous regenerative capacity facing up to aging of the musculoskeletal system   7/1/2019 - 6/30/2023  PhD Janja Zupan   2,597 
5. J3-1759  Comprehensive characterization of GWAS hits – pipeline to novel drug targets for anabolic treatment of osteoporosis (GWASforAna)   7/1/2019 - 6/30/2022  PhD Janja Marc   5,275 
6. J1-8140  Endokrini in genotoksični potencial inhibitorjev proteinskih kinaz: pomen za tveganja za okolje in zdravje ljudi (Slovene)   5/1/2017 - 4/30/2020  PhD Metka Filipič   4,118 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2015 - 12/31/2021 PhD Stanislav Gobec   6,669 
Confirmation required
Views history
Favourite